GM3 suppresses anchorage-independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells

Pu Wang1, Su Xu, Yinan Wang

  • 1Laboratory of Tumor Biology and Glycobiology, Department of Life Sciences, Shenyang Pharmaceutical University, Shenyang, China.

Cancer Science
|April 27, 2011
PubMed

Insights

GM3 ganglioside suppresses anchorage-independent growth in melanoma cells by upregulating Ly-GDI (Rho GTPase dissociation inhibitor beta) expression. This occurs via the PI3K/Akt/mTOR signaling pathway, highlighting a novel mechanism for controlling melanoma cell behavior.

Area of Science:

  • * Cell Biology
  • * Cancer Research
  • * Glycobiology

Background:

  • * Melanoma progression is linked to altered cell growth and adhesion properties.
  • * Gangliosides, like GM3, play roles in cell signaling and cancer.
  • * Rho GTPase dissociation inhibitors regulate cell motility and growth.

Purpose of the Study:

  • * To elucidate the role of GM3 ganglioside in regulating melanoma cell anchorage-independent growth.
  • * To identify the signaling pathway involved in GM3-mediated regulation of Ly-GDI expression.
  • * To investigate the functional link between GM3, Ly-GDI, and melanoma cell proliferation.

Main Methods:

  • * Manipulation of GM3 and Ly-GDI levels using cDNA transfection and siRNA.
  • * Assessment of anchorage-independent growth using soft agar assays.
  • * Pharmacological inhibition and genetic silencing of key signaling molecules (PI3K, Akt, mTOR pathway components).

Main Results:

  • * GM3 addition increased Ly-GDI expression, while suppression of either decreased it, correlating with altered anchorage-independent growth.
  • * GM3-induced Ly-GDI expression was mediated by the PI3K/Akt/mTOR pathway, involving Akt phosphorylation at Thr308 and mTOR/Raptor complex.
  • * Inhibition of Pdpk1 blocked Akt phosphorylation and GM3 sensitivity, confirming Akt-Thr308's critical role.
  • * Components of this pathway mimicked the effects of GM3 and Ly-GDI on anchorage-independent growth.

Conclusions:

  • * GM3 ganglioside suppresses anchorage-independent growth in B16 melanoma cells through Ly-GDI.
  • * The PI3K/Akt/mTOR pathway, specifically involving Pdpk1 and mTOR/Raptor, mediates GM3 signaling to Ly-GDI.
  • * Targeting the GM3-Ly-GDI axis offers potential therapeutic strategies for melanoma.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...